[Rescheduled from Friday] Views of Pharmacogenetics and Tobacco Cessation Among Alaska Native People:Preliminary Findings

Saturday, October 18, 2014: 3:45 PM-5:15 PM
LACC 507 (Los Angeles Convention Center)
Chair:
Rosalina James, PhD, Assistant Professor, University of Washington

Description: Pharmacogenetic testing (PGX) offers opportunities to increase efficacy of the tobacco cessation program however, little is known about barriers to PGX in Alaska Native/American Indian communities. To inform future programs, we conducted semi-structured interviews. The majority of stakeholders endorse the use of PGX to guide tobacco cessation in primary care.



3:45 PM
Introductory Remarks
3:50 PM
TBD
Denise Dillard, PhD , Research Director , Southcentral Foundation
4:10 PM
Views of Pharmacogenetics and Tobacco Cessation Among Alaska Native People: Preliminary Findings
Renee Robinson, PharmD , Senior Researcher , Southcentral Foundation
4:30 PM
Characterization Gene Variation Known to Affect Nicotine and Nicotine Cessation Treatment Metabolism
Kenneth Thummel, PhD , Department Chair , University of Washington Seattle